25 May 2013
Keywords: centocor, cnto, impresses, psoriasis, study, usa-based, subsidiary
Article | 19 February 2007
USA-based Centocor, a subsidiary of global health care major Johnson & Johnson, says that the results of a Phase II trial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 February 2007
26 February 2007
24 May 2013
© 2013 thepharmaletter.com